Comparison between infusion and bolus of Tranexamic acid to reduce bleeding in Cyanotic congenital heart disease surgeries.
Comparison between Intravenous Boluses versus Infusion of Tranexamic Acid (TXA) to Reduce Bleeding In Paediatric Cyanotic CHD Surgeries; A Randomized Clinical Control Trial.
Irfan Akhter
60 participants
Jul 16, 2016
Interventional
Conditions
Summary
Excessive bleeding in both adults and paediatric cardiac surgery increases morbidity and mortality. Paediatric patients undergoing cardiac surgery are at high risk for intraoperative and postoperative bleeding.Increased bleeding in children exposes them to transfusion of blood and blood products, hence increased risk of complications associated with transfusion. Tranexamic acid is being used to reduce bleeding but there is no specific dose or regimen. We compared two different regimens of Tranexamic acid i.e infusion and bolus to see which is better in terms of Post-operative bleeding, chest closure time and blood products usage.
Eligibility
Inclusion Criteria4
- Age group: Neonates to 16 yrs.
- Cyanotic Congenital heart surgery.
- Use of cardiopulmonary bypass.
- First open heart surgery
Exclusion Criteria4
- Renal dysfunction (Serum creatinine >1.5 mg/dl)
- Previous neurological event
- Congenital or Acquired bleeding disorder (INR>1.5, H/O Easy bruisebility)
- Allergic to tranexamic acid (1ml=50mg test dose to test allergy).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Tranexamic acid Infusion (considered as intervention) - intravenous infusion at 5 mg/kg/hour started induction and continued throughout surgery and ICU stay till post-operative bleeding drops to less than 0.5-1 ml/kg/hour.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12617001176358